Definitive Contract HHSF223201710118C
Award Date
9/14/17
Potential Completion Date
7/31/18
Potential Value
$100K
Federal Agency
Food and Drug Administration
Awardee
Clinicahealth, Inc.
Ultimate Awardee
Not listed
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Arlington, VA 22201, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
27
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $125,000.00 firm fixed price definitive contract awarded by the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Clinicahealth, Inc., a for-profit organization, on September 16, 2019. The contract is for "SOCIAL LISTENING FOR PATIENT PERSPECTIVE ON CHRONIC PAIN STUDY-OPTION B" with a completion date of September 15, 2020. The contract does not have a set-aside designation. The place of performance is Arlington, VA 22201, USA. This contract...
This is a $180,000 firm fixed price purchase order awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Clarivate Analytics (Us) LLC, a global provider of scientific and medical research databases and analytics tools. The contract is for data acquisition services related to active pharmaceutical ingredients (APIs), including information on API manufacturing facilities and activities. This single-award contract has a completion date of September 24, 2021....
<p>This is a $9,671,431.00 Firm Fixed Price contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Safe Health Systems, Inc., a self-certified small disadvantaged business. The contract is for stimulating innovation in clinical evaluations and personalized medicine to improve product development and patient outcome. The contract has no set-aside designation and has an ultimate completion date of March 27, 2026.</p>
This is a $1,353,024.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority, doing business as Denver Health, to harness diverse data through information sciences to improve health outcomes, evaluate bias, recruitment, and retention in an online setting, conduct a recruitment and retention optimization study, and perform content validation of questionnaire modules. The contract supports a pilot study for these...
The Department of Health and Human Services' Food and Drug Administration (FDA) awarded a firm fixed-price definitive contract worth $595,345.32 to Mark Herring Associates, Inc., a for-profit organization and Subchapter S Corporation. The contract is for a two-phase project, with Phase One involving the collection, analysis, interpretation, and reporting of qualitative data from approximately 140 individuals who have used prescription opioids and at least one of four other substances. The work...
This is a $502,884.58 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Administration (OASA), a civilian federal agency, to Health Resources In Action, Inc. (HRIA), a non-profit organization doing business as The Medical Foundation. The contract is for "Engaging Community Health Workers to Prevent Cardiovascular-Related Morbidity and Mortality" and "Approaches to CHW Financial Sustainability." HRIA has extensive experience providing...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Food and Drug Administration (FDA) to the American Institutes for Research in the Behavioral Sciences (AIR), a non-profit research organization. The contract, valued at $653,236.51, will explore healthcare providers' perceptions and experiences with public health emergency misinformation. The contract is not set aside for small businesses and is part of AIR's Multiple Award Schedule (MAS) contract vehicle,...
This definitive, firm fixed-price contract was awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to CFD Research Corporation, a for-profit organization, to develop a multiscale computational framework for assessing the bioequivalence of orally inhaled drugs. The $499,761 contract does not have a set-aside designation. The original solicitation was a Broad Agency Announcement (BAA) seeking research and development to advance FDA's mission of protecting...
This is a $1,945,000.00 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA) to Health and Environmental Sciences Institute (HESI), a non-profit organization based in Washington, DC. The contract is for assessing the variability and reproducibility of manual and automated patch clamp platforms, which are used to evaluate drug safety and biological activity. The contract does not have a set-aside designation and has an ultimate completion date of December 31,...
This federal contract award, valued at $1,403,705.20, was issued by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The contract is a delivery order issued under the Tobacco Products Pharmacology Study master indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The contract does not have a set-aside designation. LBERI, a non-profit contract research organization,...